NF1 may serve as a novel genetic biomarker of response to treatment and prognosis in glioblastoma (GBM).

e14539Background: The intrinsic capacity of glioblastoma (GBM) tumor cells to infiltrate normal brain predictably results in high rates of early recurrence. Little has changed over the last decade ...